Clinical Trials Logo
  1. Home
  2. Cardiovascular Risk
  3. NCT01139827
  4. Details
NCT01139827 Clinical Trial

Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography

Cardiovascular Risk Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01139827
Other study ID # PET(FRS-CRP)
Secondary ID
Status Completed
Phase N/A
First received June 8, 2010
Last updated June 8, 2010
Start date September 2009
Est. completion date February 2010

Study information
Verified date February 2010
Source Korea University Guro Hospital
Contact n/a
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

Framingham risk score is well known screening tool that detect cardiovascular (CV) risk. But it is not suitable for CV risk in mild risk group. So 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a new imaging technique for detecting vascular inflammation within atherosclerotic plaques and hsCRP is also arising detection tool of CV risk.

The investigators are examining this association in normal and impaired glucose tolerance patients groups.

Description:

We examined vascular inflammation using FDG-PET scan in 178 subjects (Normal and impaired glucose tolerance groups). Vascular 18F-FDG uptake was measured as both the mean and maximum blood-normalized standardized uptake value (SUV), known as the target-to-background ratio (TBR). And We analyzed that the association with Framingham risk score, hs CRP and vascular inflammation by FDG-PET scan.

Recruitment information / eligibility
Status Completed
Enrollment 178
Est. completion date February 2010
Est. primary completion date February 2010
Accepts healthy volunteers No
Gender Both
Age group 16 Years to 80 Years
Eligibility Inclusion Criteria:

- healthy subjects

Exclusion Criteria:

- a history of cardiovascular disease (myocardial infarction, unstable angina, stroke or cardiovascular revascularization)

- active inflammatory disease, recent active infection

- stage 2 hypertension (resting blood pressure, = 160/100 mmHg)

- diabetes mellitus

- systemic disorders such as severe hepatic, renal, and hematologic diseases

- taking drugs known to interfere with vascular inflammation measured by FDG-PET.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
Korea, Republic of Korea university guro hospital Seoul

Sponsors (1)
Lead Sponsor Collaborator
Korea University Guro Hospital

Country where clinical trial is conducted

Korea, Republic of, 

See also
  Status Clinical Trial Phase
Recruiting NCT05767073 - LIVES: Personalized Lifestyle Intervention for Patients With Depression N/A
Completed NCT04626505 - Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. Phase 2
Completed NCT00856882 - The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors N/A
Completed NCT04330937 - Clinical Trial on the Effectiveness of Citrolive N/A
Completed NCT01781416 - Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk N/A
Completed NCT01475513 - Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women Phase 4
Enrolling by invitation NCT06122961 - Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed NCT04506749 - To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects N/A
Completed NCT03412175 - CREATION Health Lifestyle Intervention N/A
Completed NCT02144922 - Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients Phase 4
Completed NCT00921752 - C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS) N/A
Completed NCT00697580 - Strength and Nutrition Outcomes for Latino Adolescents N/A
Enrolling by invitation NCT04450914 - Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP) N/A
Completed NCT01003574 - Evaluation of Cardiovascular Health Outcomes Among Survivors N/A
Not yet recruiting NCT06118281 - ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Phase 3
Completed NCT01441323 - Strength Training and Nutrition Development for African American Youth N/A
Completed NCT01103648 - Effect of Simvastatin and Ezetimibe on Lipid and Inflammation N/A
Completed NCT01015092 - Cardiovascular Risk Evaluation and Antiretrovirals in HIV N/A
Not yet recruiting NCT05882266 - The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals With Cardiovascular(CVD) Risk N/A
Completed NCT00988754 - School Based Health Promotion Program in Secondary Schools N/A